Literature DB >> 23581870

Measurement and Treatment Research toImprove Cognition in Schizophrenia Consensus Cognitive Battery: validation of the Japanese version.

Yasuhiro Kaneda1, Tetsuro Ohmori, Yuko Okahisa, Tomiki Sumiyoshi, Shenghong Pu, Yoshinori Ueoka, Manabu Takaki, Kazuyuki Nakagome, Ichiro Sora.   

Abstract

AIM: This preliminary study was performed to test the reliability and validity of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB), developed by the National Institute of Mental Health MATRICS initiative, as an assessment tool in a Japanese-language version (MCCB-J).
METHODS: The subjects for the present study were 37 patients with schizophrenia. Each subject gave written informed consent to participate in the research. In order to examine the validity of the MCCB-J, the correlation between the MCCB-J and the Japanese-language version of the Brief Assessment of Cognition in Schizophrenia (BACS) was determined.
RESULTS: Cronbach's alpha for the MCCB-J was 0.72. The MCCB-J composite score was significantly correlated with all subtests of the MCCB-J. There was a significant correlation between the MCCB-J and the BACS composite score.
CONCLUSION: This preliminary study indicates that the MCCB-J has good psychometric properties and validity.
© 2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23581870     DOI: 10.1111/pcn.12029

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  17 in total

1.  What is the optimal neuropsychological test battery for schizophrenia in China?

Authors:  Chuan Shi; Lan Kang; Shuqiao Yao; Yibin Ma; Tao Li; Ying Liang; Zhang Cheng; Yifeng Xu; Jianguo Shi; Xiufeng Xu; Congpei Zhang; Donald R Franklin; Robert K Heaton; Hua Jin; Xin Yu
Journal:  Schizophr Res       Date:  2019-02-01       Impact factor: 4.939

2.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

3.  Olfactory deficits in individuals at risk for psychosis and patients with schizophrenia: relationship with socio-cognitive functions and symptom severity.

Authors:  Tsutomu Takahashi; Mihoko Nakamura; Daiki Sasabayashi; Yuko Komori; Yuko Higuchi; Yumiko Nishikawa; Shimako Nishiyama; Hiroko Itoh; Yuri Masaoka; Michio Suzuki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-10-25       Impact factor: 5.270

4.  Prolonged P300 Latency in Antipsychotic-Free Subjects with At-Risk Mental States Who Later Developed Schizophrenia.

Authors:  Yuko Higuchi; Tomiki Sumiyoshi; Takahiro Tateno; Suguru Nakajima; Daiki Sasabayashi; Shimako Nishiyama; Yuko Mizukami; Tsutomu Takahashi; Michio Suzuki
Journal:  J Pers Med       Date:  2021-04-21

5.  Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study.

Authors:  Naoki Hashimoto; Atsuhito Toyomaki; Minoru Honda; Satoru Miyano; Nobuyuki Nitta; Hiroyuki Sawayama; Yasufumi Sugawara; Keiichi Uemura; Noriko Tsukamoto; Tsukasa Koyama; Ichiro Kusumi
Journal:  Ann Gen Psychiatry       Date:  2015-01-22       Impact factor: 3.455

6.  Cognitive insight and functional outcome in schizophrenia; a multi-center collaborative study with the specific level of functioning scale-Japanese version.

Authors:  Tomiki Sumiyoshi; Keiichiro Nishida; Hidehito Niimura; Atsuhito Toyomaki; Tsubasa Morimoto; Masayuki Tani; Ken Inada; Taiga Ninomiya; Hikaru Hori; Jun Manabe; Asuka Katsuki; Takamitsu Kubo; Yosuke Koshikawa; Masanao Shirahama; Kentaro Kohno; Toshihiko Kinoshita; Ichiro Kusumi; Akira Iwanami; Takefumi Ueno; Toshi Kishimoto; Takeshi Terao; Kazuyuki Nakagome
Journal:  Schizophr Res Cogn       Date:  2016-09-28

7.  Association of fronto-temporal function with cognitive ability in schizophrenia.

Authors:  Shenghong Pu; Kazuyuki Nakagome; Masashi Itakura; Masaaki Iwata; Izumi Nagata; Koichi Kaneko
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

8.  The relationship between IQ and performance on the MATRICS consensus cognitive battery.

Authors:  Christine Mohn; Kjetil Sundet; Bjørn Rishovd Rund
Journal:  Schizophr Res Cogn       Date:  2014-08-27

9.  Factors predicting work outcome in Japanese patients with schizophrenia: role of multiple functioning levels.

Authors:  Chika Sumiyoshi; Philip D Harvey; Manabu Takaki; Yuko Okahisa; Taku Sato; Ichiro Sora; Keith H Nuechterlein; Kenneth L Subotnik; Tomiki Sumiyoshi
Journal:  Schizophr Res Cogn       Date:  2015-09-09

10.  Utility of the UCSD Performance-based Skills Assessment-Brief Japanese version: discriminative ability and relation to neurocognition.

Authors:  Chika Sumiyoshi; Manbu Takaki; Yuko Okahisa; Thomas L Patterson; Philip D Harvey; Tomiki Sumiyoshi
Journal:  Schizophr Res Cogn       Date:  2014-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.